Lawsuit Overview
September 1, 2015 (Shareholders Foundation) - An investor in NASDAQ:GERN shares filed a lawsuit against certain of Geron over alleged breaches of fiduciary duties that caused damages to the company and its stockholders. The plaintiff claims that defendants failed to side effects of its sole product, a cancer drug, and shares of Geron Corporation (NASDAQ:GERN) declined from $4.40 to ...
You must register (for free) or login to view the entire case.